This study, published in the New England Journal of Medicine, evaluated the safety and efficacy of GSK’s rotavirus vaccine (Rotarix®), with a focus on determining risk of intussusception.

This article, published in the Journal of Infectious Diseases, describes a novel cell culture-derived influenza vaccine (CCIV) produced in Madin-Darby canine kidney cells. The Phase 3, multicenter study in Poland observed that CCIV was well …

In travelers often several pre-departure immunizations are indicated, thus data are needed about possible interactions between vaccines. This Phase 3 study investigated the immunogenicity and safety of IC51 (JE vaccine) and HAVRIX1440 (hepatitis A …

This study, published in the New England Journal of Medicine, assessed the feasibility of integrating the RTS,S/AS02D malaria vaccine into a standard expanded program on immunization (EPI) schedule for infants. The study, conducted in …

This article, published in The Pediatric Infectious Disease Journal, reviews a study that administered three doses of a bivalent meningococcal A + C diphtheria-toxoid-conjugated vaccine (MenD), containing 1, 4, or 16 μg of each …

This article, published in the journal Vaccine, discusses a double-blind, randomized, controlled Phase 1 study in India to assess safety, immunogenicity, and antibody persistence of the new meningococcal group A conjugate vaccine (PsA-TT) …

From the Bulletin of the World Health Organization, this report is an evaluation of a "logistic approach" on immunization injection safety. The investigators found that unsafe injection practices were generally due to a failure to …

This study, published in the journal Vaccine, evaluated the safety of the RTS,S/AS02A malaria vaccine in a proof of concept Phase IIb trial in Mozambican children aged one to four years. Overall, the study results indicate that the …

This publication aims to address confusion created by contradictory information in the public domain regarding immunization. It sets out to explain the current situation in immunization science, including where there is consensus in the scientific …

This document reports on a high-level meeting about setting the immunization agenda through advocacy and communication, held in London in January 2008. The meeting was held jointly by the United Kingdom Department of Health and the World …

Published in the journal Vaccine, this article discusses the return of investigators to Nepali villages where they conducted a case control study that revealed 99 percent efficacy after one year among children who received a single dose of the …

This report focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals. It looks at the development and use of vaccines and the …

This statement summarizes several post-licensure evaluations on rotavirus vaccines and intussusception that were presented to the US Advisory Committee on Immunization Practices. Some studies performed outside the United States have detected a …

This issue of the Weekly Epidemiological Record reports on the World Health Organization's Strategic Advisory Group of Experts' recommendation for inclusion of rotavirus vaccines in all national immunization programs. The new …

This study, published in the Journal of Infectious Diseases, assessed the safety, reactogenicity, and immunogenicity of an injectable cell culture-derived influenza vaccine, compared with those of an injectable egg-based trivalent inactivated …

This web page contains links a number of vaccine safety resources, including websites, journal articles, and fact sheets.

This web page provides a US Centers for Disease Control and Prevention (CDC) statement on the safety of thimerosal in vaccines and links to CDC and outside resources that provide further information on this topic. 

This page contains information on thimerosal, a mercury-containing preservative that has been used in vaccines. The page also includes links to other resources on thimerosal and vaccines.

This World Health Organization link provides answers to 20 common questions about thimerosal.

This information sheet covers issue relating to the use of thiomersal (also known as thimerosal) in vaccines, including why it is used, evidence regarding safety, and the World Health Organization's position on the issue.

This in-depth fact sheet provides common questions and answers related to the use of thiomersal (also known as thimerosal) in vaccines. It includes general information about thiomersal, which vaccines contain it and why, updates on additional …

This article, published in the Journal of Infectious Diseases, reports on surveillance conducted following rotavirus vaccine introduction in 2006 that noted a small increase in intussusception among US infants aged 8 to 11 weeks, who would have …

This fact sheet explains what thimerosal is and why it is used as a preservative in some multi-dose vials of influenza vaccine, and highlights conclusions from studies examining thimerosal safety in vaccines.

This project was formed to build a multi-disciplinary network of biomedical scientists, decision scientists, psychologists, and social scientists to examine the influences and decision-making processes as individuals around the world, including …

An unprecedented increase in new vaccine development has occurred over the past three decades. This article, published in The Lancet, discusses new methods of discovery, such as reverse vaccinology, structural biology, and systems biology, which …